Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lown

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|May 7, 2021
Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE TrialJames P Sheppard, Mark Lown, Jenni Burt, et al.
Plos One|April 22, 2025
Development of a complex multidisciplinary medication review and deprescribing intervention in primary care for older people living with frailty and polypharmacyEloise Radcliffe, Alejandra Recio Saucedo, Clare Howard, et al.
BJGP Open|March 4, 2026
Implementing a medication review and deprescribing intervention for older people living with frailty and polypharmacy in general practice: a feasibility studyEloise Radcliffe, Ngianga Kandala, Tracey Sach, et al.
Frontiers in Aging|July 13, 2022
Relationships Between Age, Frailty, Length of Care Home Residence and Biomarkers of Immunity and Inflammation in Older Care Home Residents in the United KingdomVivian M Castro-Herrera, Mark Lown, Helena L Fisk, et al.
BMJ Open|January 31, 2025
plaTform fOr Urinary tract infection diagnostiC evAluatioN (TOUCAN): a protocol for a prospective diagnostic accuracy study of point-of-care testing in patients suspected of acute uncomplicated urinary tract infection in primary care clinics in EnglandPhilip J Turner, Thomas R Fanshawe, Jane Freeman, et al.
Journal of Medical Internet Research|April 26, 2024
Correction: Internet Tool to Support Self-Assessment and Self-Swabbing of Sore Throat: Development and Feasibility StudyMark Lown, Kirsten Smith, Ingrid Muller, et al.
Frontiers in Immunology|March 22, 2021
Combination of the Probiotics <i>Lacticaseibacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i>, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled TrialVivian M Castro-Herrera, Helena L Fisk, Mandy Wootton, et al.
Journal of Medical Internet Research|December 8, 2023
Internet Tool to Support Self-Assessment and Self-Swabbing of Sore Throat: Development and Feasibility StudyMark Lown, Kirsten A Smith, Ingrid Muller, et al.
BMC Geriatrics|September 24, 2023
What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesisEloise Radcliffe, Renée Servin, Natalie Cox, et al.
Trials|April 22, 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney diseaseHugh Gallagher, Jennifer Dumbleton, Tom Maishman, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|May 7, 2021
Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE TrialJames P Sheppard, Mark Lown, Jenni Burt, et al.
Plos One|April 22, 2025
Development of a complex multidisciplinary medication review and deprescribing intervention in primary care for older people living with frailty and polypharmacyEloise Radcliffe, Alejandra Recio Saucedo, Clare Howard, et al.
BJGP Open|March 4, 2026
Implementing a medication review and deprescribing intervention for older people living with frailty and polypharmacy in general practice: a feasibility studyEloise Radcliffe, Ngianga Kandala, Tracey Sach, et al.
Frontiers in Aging|July 13, 2022
Relationships Between Age, Frailty, Length of Care Home Residence and Biomarkers of Immunity and Inflammation in Older Care Home Residents in the United KingdomVivian M Castro-Herrera, Mark Lown, Helena L Fisk, et al.
BMJ Open|January 31, 2025
plaTform fOr Urinary tract infection diagnostiC evAluatioN (TOUCAN): a protocol for a prospective diagnostic accuracy study of point-of-care testing in patients suspected of acute uncomplicated urinary tract infection in primary care clinics in EnglandPhilip J Turner, Thomas R Fanshawe, Jane Freeman, et al.
Journal of Medical Internet Research|April 26, 2024
Correction: Internet Tool to Support Self-Assessment and Self-Swabbing of Sore Throat: Development and Feasibility StudyMark Lown, Kirsten Smith, Ingrid Muller, et al.
Frontiers in Immunology|March 22, 2021
Combination of the Probiotics <i>Lacticaseibacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i>, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled TrialVivian M Castro-Herrera, Helena L Fisk, Mandy Wootton, et al.
Journal of Medical Internet Research|December 8, 2023
Internet Tool to Support Self-Assessment and Self-Swabbing of Sore Throat: Development and Feasibility StudyMark Lown, Kirsten A Smith, Ingrid Muller, et al.
BMC Geriatrics|September 24, 2023
What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesisEloise Radcliffe, Renée Servin, Natalie Cox, et al.
Trials|April 22, 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney diseaseHugh Gallagher, Jennifer Dumbleton, Tom Maishman, et al.
Pageof 6